LTEP-a2 人肺腺癌细胞 Catalogue No.: C1316 Product Format: a T25 flask Culture Properties:贴壁 Complete Growth Medium:89%1640+10%FBS+1%双抗 Atmosphere: air, 95%; carbon dioxide (CO2), 5% Application:Cells and cancer research NOTE: FOR RESEARCH USE ONLY.
Components
Item
Specifications
a T25 flask
2X106
Manual
1 copy
19156044901 (同微信)
both patients with advanced pklanoma and those with advanced NSCLC. In patients with advanced pklanoma, both PD-1 inhibitors (nivolumab and pembrolizumab) have shown improved survival versus ipilimumab. PD-1 inhibitors are associated with adverse events that have immune